Immune therapies for neuroblastoma. - Wikidata - awgldk - TriplyDB

Immune therapies for neuroblastoma.

Immune therapies for neuroblastoma.

http://www.wikidata.org/entity/Q37431356

about

Cancer Stem Cells and Their Interaction with the Tumor Microenvironment in Neuroblastoma Comparison of GD2 binding capture ELISA assays for anti-GD2-antibodies using GD2-coated plates and a GD2-expressing cell-based ELISA Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: potential predictors of successful clinical outcome based on observations in high-risk neuroblastoma.Pre-Clinical Evaluation of rHDL Encapsulated Retinoids for the Treatment of Neuroblastoma.Targeted immunotherapy for high-risk neuroblastoma--the role of monoclonal antibodies.Preparation of Fab-fragments of GD2-specific antibodies and analysis of their antitumor activity in vitro.A very rare adult case with neuroblastoma.Targeted delivery to neuroblastoma of novel siRNA-anti-GD2-liposomes prepared by dual asymmetric centrifugation and sterol-based post-insertion method.Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission.Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation.Treatment and survival of childhood neuroblastoma: Evidence from a population-based study in the United States.Expression of Disialoganglioside (GD2) in Neuroblastic Tumors: A Prognostic Value for Patients Treated With Anti-GD2 Immunotherapy.

P2860

Q26771238-F5586C2F-C89C-4A35-BC75-824473A9337F Q35381031-9B039234-DE58-4D46-A38E-8735FFAA0BCA Q35963440-9F3339F7-88BB-48E7-82BF-20672B1661BB Q37475635-7F232E34-CBBF-4F68-BD42-CA87D0FA49FF Q38079519-9C3EC925-9430-4EEF-A10D-3A653A4D45FF Q39154389-679BFCC0-F1A8-445D-A955-5D82D38B40C5 Q39256459-B1D7E653-489D-47A9-BD15-57A3D39AD7B2 Q39539998-7179891A-AE56-4C7E-9D9E-FF784687A670 Q41394300-6C7489E4-6BAF-4ED0-82B4-78FFF91E4F96 Q41577518-920C41C4-6BB5-4A24-918A-9F6CFC23902F Q42697385-017E14A4-B2DD-48E4-88B3-C73B4AEF1402 Q50079732-D9B15BEB-BA96-4540-83B2-D8ED58E78AF2

P2860

Immune therapies for neuroblastoma.

http://www.wikidata.org/entity/Q37431356

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Immune therapies for neuroblastoma.

@en

Immune therapies for neuroblastoma.

@nl

type

label

Immune therapies for neuroblastoma.

@en

Immune therapies for neuroblastoma.

@nl

prefLabel

Immune therapies for neuroblastoma.

@en

Immune therapies for neuroblastoma.

@nl

P1433

Q37431356-A2800C01-E6D2-40DB-8C39-F5B54A16D6D6

P1476

Q37431356-DBEC9A0E-BAAF-4060-9416-0A32EF697C8E

P2093

Q37431356-010DD28B-C403-4F86-8B34-D7148D9B9AB9

Q37431356-4420FFB5-103B-4972-BA5E-B102935D8504

Q37431356-BBAC997A-5F2C-441D-A141-EF04F583A845

P2860

Q37431356-065446A4-CA9E-4B70-85F1-BF72CD42E91C

Q37431356-0C5EFA54-F4BA-4D0E-AD71-CBC0DFB33BAB

Q37431356-115DC711-6AF2-4978-8D2C-855C3C74E476

Q37431356-13BA3F1C-09D5-4ABE-B8A1-82084AB3CF78

Q37431356-140A0AD8-A324-4577-9DB2-C0069AFC2AC6

Q37431356-175A7C83-D5F7-4A08-A315-5AFC466B2E84

Q37431356-1B96FBCC-9D19-496E-B121-F4E03C17FB81

Q37431356-1E318E9E-9405-4A1E-8199-A1E7EC201AAD

Q37431356-1EF7719E-73CD-409B-A0FD-257243C1261E

Q37431356-218EE01B-8962-4957-933D-86485D948E24

P304

Q37431356-D1BCEA10-DEF0-4D68-97FE-BFA8050F287F

P31

Q37431356-3D6DE706-BCF3-4F4D-822A-542A11862E0B

P356

Q37431356-B261B6C5-5B21-40E5-8A6A-D076F26C33F1

P433

Q37431356-34F60721-5E86-48D3-8ED5-7D2777CFFABD

P478

Q37431356-2C32BF34-FA7E-446E-A1D4-662322C4C630

P577

Q37431356-8828F046-BDD3-4927-9C10-AC3B6D27D16C

P5875

Q37431356-4E93AB66-7D8A-455D-A053-F731F57FB717

P698

Q37431356-28614BAA-E71E-4F60-A2BF-882D6640EEE9

P932

Q37431356-D51BAC4A-63F2-40B4-85BC-8EB4546E707A

P356

P1433

Cancer Biology and Therapy

P1476

Immune therapies for neuroblastoma.

@en

P2093

Fariba Navid

http://www.w3.org/2001/XMLSchema#string

Michael Armstrong

http://www.w3.org/2001/XMLSchema#string

Raymond C Barfield

http://www.w3.org/2001/XMLSchema#string

P2860

Toll-like receptor control of the adaptive immune responses

Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients.

A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children older than 1 year with metastatic neuroblastoma.

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

Antigen processing and presentation by the class I major histocompatibility complex.

GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma.

Molecular mechanisms regulating Th1 immune responses.

P304

874-882

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CBT.8.10.8358

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24254417

http://www.w3.org/2001/XMLSchema#string

P698

19342881

http://www.w3.org/2001/XMLSchema#string

P932

2712572

http://www.w3.org/2001/XMLSchema#string